Dechra Sustainability Profile
Dechra Pharmaceuticals PLC, commonly known as Dechra, is a leading global veterinary pharmaceutical company headquartered in the United Kingdom. Founded in 1997, Dechra has established a strong presence in Europe, North America, and Australia, focusing on the development and marketing of high-quality products for companion animals and livestock. Specialising in veterinary medicines, Dechra offers a diverse range of core products, including anaesthetics, dermatology treatments, and nutritional supplements. What sets Dechra apart is its commitment to innovation and quality, ensuring that its products meet the highest standards of safety and efficacy. With a robust market position, Dechra has achieved significant milestones, including numerous product launches and strategic acquisitions, solidifying its reputation as a trusted partner in animal health. The company continues to lead the way in veterinary pharmaceuticals, dedicated to improving the health and well-being of animals worldwide.
DitchCarbon Score
How does Dechra's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dechra's score of 62 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dechra's reported carbon emissions
In 2022, Dechra Pharmaceuticals PLC reported total greenhouse gas emissions of approximately 144.5 million kg CO2e, comprising 7,596,000 kg CO2e from Scope 1, 4,413,000 kg CO2e from Scope 2, and 319,498,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 42% by 2030 from a 2021 base year and achieve a 90% reduction by 2050. Additionally, Dechra targets a 51.6% reduction in Scope 3 emissions per GBP value added by 2030, with a long-term goal of a 97% reduction by 2050. Dechra's net-zero commitment encompasses all scopes, with a target to reach net-zero emissions across its value chain by 2050. These targets align with the Science Based Targets initiative (SBTi) and reflect the company's dedication to sustainable practices within the pharmaceuticals sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 6,747,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 4,969,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 2,347,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Dechra's Industry?
How Carbon Intensive is Dechra's Location?
Dechra's Scope 3 Categories Breakdown
Dechra's Scope 3 emissions, which decreased by 34% last year and increased significantly since 2020, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 17% of Scope 3 emissions.
Top Scope 3 Categories
Dechra's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dechra has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Dechra's sustainability data and climate commitments
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.